No Surprises Act regulations remain a moving target for compliance
Amid all the rules stemming from the No Surprises Act, a looming mandate for providers to send cost estimates to health plans looks like the biggest stress inducer.
Recent changes to E/M coding mean time-based billing could be advantageous for longer visits, study finds
Depending on patient volumes, clinics could benefit from incorporating time-based billing instead of relying on CPT coding approaches.
Hospitalists are more likely than other physicians to choose high-intensity codes for inpatient care, study finds
The billing and coding practices of hospitalists may contribute to the rising cost of hospital care in the U.S., according to conclusions of a new study.
Revenue Cycle Insights: February 2022
This month's issue leads off with the news that the federal government is taking a look at provider billing in the COVID era through audits by the Office of Inspector General.
Providers must furnish ‘good-faith’ price estimates to self-pay patients starting next year
A newly issued federal rule on surprise billing includes regulations designed to improve price transparency for self-pay patients.
AMA releases 2022 CPT code set with new options that apply to COVID-19 vaccination, digital care services and more
The new set features more than 400 CPT code changes from 2021.
In 2022 OPPS rule, CMS plans to reinstate policies pertaining to the inpatient-only and ASC covered-procedures lists
The 2022 proposed rule for the Outpatient Prospective Payment System would reverse 2021 policies that began to phase out the inpatient-only list of procedures and expand the covered-procedures list for ambulatory surgical centers.
Medicare should update its policies for separately payable drugs in the Outpatient Prospective Payment System, MedPAC says
Worthwhile changes include requiring drugs to be proven clinically superior before granting them pass-through payment status, according to a new report.
How healthcare organizations can leverage CDI to meet strategic goals amid times of financial uncertainty
Six trends related to the COVID-19 pandemic have created a need for healthcare organizations to adopt a new, strategic and data-driven approach to managing their clinical documentation integrity (CDI) programs.
Update on Medicare payment policy for treatments involving bamlanivimab
Medicare no longer will pay healthcare providers for administering the COVID-19 treatment bamlanivimab now that the FDA has revoked the Emergency Use Authorization for treatments in which the drug is administered alone.